PACS1 and colorectal cancer: Therefore, the findings advocate for further investigations into the prognostic capabilities of PACS1 and emphasize the necessity of integrated cfRNA assessments, which may enhance patient stratification and therapeutic decision-making in colorectal cancer management, thereby influencing future molecular oncology approaches.